Can-Fite BioPharma Ltd. (TLV:CANF)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1.300
0.00 (0.00%)
Jun 26, 2025, 5:24 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 51.14 million as of June 27, 2025. Its market cap has increased by 17.78% in one year.
Market Cap
51.14M
Enterprise Value
22.79M
Revenue
2.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.30
Market Cap Chart
Since June 12, 2006, Can-Fite BioPharma's market cap has increased from 16.04M to 51.14M, an increase of 218.83%. That is a compound annual growth rate of 6.27%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 66.64B |
| Danel (Adir Yeoshua) | 2.80B |
| Kamada | 1.53B |
| Bait Bakfar | 1.06B |
| BrainsWay | 801.90M |
| Novolog (Pharm-Up 1966) | 722.84M |
| SofWave Medical | 713.46M |
| Ilex Medical | 711.56M |